Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 48, Issue 1, Pages 1-15Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2009.09.026
Keywords
TGF-beta; Oxidative stress; Fibrosis; Glutathione; Free radicals
Funding
- National Institute of Environmental Health Sciences [ES011831]
- NHLBI [5R01HL088141-02]
- American Lung Association [CI-1190-N]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088141] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011831] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Transforming growth factor beta (TGF-beta) is the most potent and ubiquitous profibrogenic cytokine. and its expression is increased in almost all the fibrotic diseases and in experimental fibrosis models. TGF-beta increases reactive oxygen species production and decreases the concentration of glutathione (GSH). the most abundant intracellular free thiol and an important antioxidant. which mediates many of the fibrogenic effects of TGF-beta in various types of cells. A decreased GSH concentration is also observed in human fibrotic diseases and in experimental fibrosis models. Although the biological significance of GSH depletion in the development of fibrosis remains obscure, GSH and N-acetylcysteine, a precursor of GSH, have been used in clinics for the treatment of fibrotic diseases. This review summarizes recent findings in the field to address the potential mechanism whereby oxidative stress mediates fibrogenesis induced by TGF-beta and the potential therapeutic value of antioxidant treatment in fibrotic diseases. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available